Page 28 - CSTE_2018-2020_AR
P. 28

Position Statements




          A position statement is a major documentation and analysis of a broad   •  19-ID-08: Revision to the Case Definition for National Pertussis
          policy or surveillance issue. Position statements are an integral part of   Surveillance
          CSTE’s work as a member-driven organization, providing programmatic   •  19-MCH-01: Neonatal Abstinence Syndrome Standardized Case
          guidance and influencing public health on national, state, and local   Definition
          levels. Position statement authors must be active CSTE members.
                                                              CSTE approved two interim position statements during the COVID-19
          Each spring, position statements are submitted to be discussed and   pandemic to create and update the standardized surveillance case
          voted on by the membership at the Annual Conference in June.   definition for COVID-19. Due to the cancellation of the 2020 CSTE
          Below is the list of approved 2019 position statements vetted by CSTE   Annual Conference, critical, time-sensitive position statements were
          membership:                                         submitted and approved as interim position statements. All interim
                                                              position statements must be ratified at the next CSTE Annual Conference
                    2019 Position Statements                  or they will become null. Below is the list of interim 2020 position
                                                              statements:
           •  19-CC-01: Nonfatal Opioid Overdose Standardized Surveillance
             Case Definition
           •  19-ID-01: Public Health Reporting and National Notification of   2020 Interim Position Statements
             Plague                                             •  20-ID-01: Standardized Surveillance Case Definition and National
           •  19-ID-02: Standardized Surveillance Case Definition for   Notification for 2019 Novel Coronavirus Disease (COVID-19)*
             Blastomycosis                                      •  20-ID-02: Update to the Standardized Surveillance Case Definition
           •  19-ID-03: Case Definition for Non-pestis Yersiniosis  and National Notification for 2019 Novel Coronavirus Disease
           •  19-ID-04: Revision to the Case Definition for National   (COVID-19)
             Legionellosis Surveillance                         •  20-ID-04: Revision to the Standardized Case Definition, Case
           •  19-ID-05: Revision to the Standardized Case Definition, Case   Classification, and Public Health Reporting for Acute Flaccid
             Classification, and Public Health Reporting for Acute Flaccid   Myelitis
             Myelitis                                           •  20-ID-05: CSTE Recommendations for Modernization of Laws to
           •  19-ID-06: Revision of the Case Definition for Hepatitis C  Prevent HIV Criminalization
           •  19-ID-07: Changes to Public Health Reporting and National
             Notification for Spotted Fever Rickettsiosis (including Rocky
             Mountain Spotted Fever)
                                                                                         *superseded by Interim 20-ID-02








                                                                                 P o sition St at emen t s  27
   23   24   25   26   27   28   29   30   31   32